d MeettheExpert sessions, all highlighting the expanding benefits of Sculptra, Relfydess and the Restylane range.1-9This comprehensive scientific presence reflects Galderma’s holistic, trendled approach to innovation, and its commitment to addressing emerging needs such as menopauserelated skin changes, the growing interest in regenerative treatments, and the rising demand for body injectables.

“Patients’ needs are changing faster than ever, whether that’s navigating the skin changes associated with menopause, seeking regenerative benefits, or looking for aesthetic harmony beyond the face. The data we’re presenting at AMWC highlight how our portfolio is uniquely positioned to meet these expectations with effective and holistic treatment regimens. At Galderma, we’re committed to leading the industry with innovations that reflect real-world patient priorities.”

BILL ANDRIOPOULOS, PH.D.
HEAD OF GLOBAL MEDICAL AFFAIRS

=*=*=*=*=*=
当前为第2/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页